Ligand ID: VGH Drugbank ID: DB08865 (Crizotinib) Indication: Crizotinib is used for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) that is anaplastic-lymphoma kinase (ALK)-positive as detected by a FDA-approved test.